Abstract #1573

Targeted modulation of retinoid signaling using polymeric nanoparticles in a mouse model of Amyotrophic Lateral Sclerosis

David Medina¹, Eugene Chung¹, Ricki Ceton¹, Robert Bowser¹, Rachael Sirianni¹, and Gregory Turner²

¹Neurobiology, Barrow Neurological Institute, Phoenix, AZ, United States, ²Research Imaging, Barrow Neurological Institute, Phoenix, AZ, United States

Retinoid signaling activity in the CNS, mediated by RARβ, directly influences ALS pathology development and progression in vivo and CNS targeted delivery of RARβ agonists can reduce ALS pathology in vivo when delivered systemically via polymeric nanoparticles. In this study the therapeutic affect of adapalene, a RARβ agonist, loaded nanoparticles were examined by measuring quadriceps volume in a SOD1^G93A mouse model of ALS.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.